Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01814072 · ClinicalTrials.gov registry record · Phase 2
Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 562
- Enrollment target
NCT01814072 is a Phase 2 study that has completed, run by Northwestern University. The registered enrollment target is 562 participants.
The verdict
NCT01814072, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 562 participants
- Enrollment target
Study Summary
The overall objective of the proposed research is to use an innovative methodological framework, the Multiphase Optimization Strategy (MOST), to design, for the first time, an optimized, scalable version of a technology-supported intensive lifestyle intervention (INLI) for obesity. MOST involves highly efficient randomized experimentation to assess the effects of individual treatment components, and thereby identify which components and component levels make important contributions to the overall program effect on weight loss. This information then guides assembly of an optimized treatment package that achieves target outcomes with least resource consumption and participant burden. Because the intervention strategies being tested minimize in-person coaching and leverage technology that participants already own, the new optimized intervention, to be called Opt-IN, will be more scalable than traditional INLIs. Opt-IN will thus enjoy greatly increased reach, and enable significant progress in the fight against obesity.
Interventions
- BEHAVIORAL Text Messages
- BEHAVIORAL 12 Telephone Coaching Sessions
- BEHAVIORAL 24 Telephone Coaching Sessions
- BEHAVIORAL Report to Primary Care Physician
- BEHAVIORAL Recommendations to use meal replacements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 562 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-09-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01814072
The ClinicalTrials.gov registry entry for NCT01814072 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 562 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Text Messages is the first listed.
NCT01814072 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01814072 about?
NCT01814072 is a clinical study titled "Opt-IN: Optimization of Remotely Delivered Intensive Lifestyle Treatment for Obesity". The overall objective of the proposed research is to use an innovative methodological framework, the Multiphase Optimization Strategy (MOST), to design, for the first time, an optimized, scalable version of a technology-supported intensive lifestyle intervention (INLI) for obesity. MOST involves hig...
What is the current status of trial NCT01814072?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 562 participants. The study started on 2013-09. Estimated completion is 2017-09-20.
What interventions are being tested in trial NCT01814072?
The interventions under investigation include: Text Messages (BEHAVIORAL), 12 Telephone Coaching Sessions (BEHAVIORAL), 24 Telephone Coaching Sessions (BEHAVIORAL), Report to Primary Care Physician (BEHAVIORAL), Recommendations to use meal replacements (BEHAVIORAL).
Who is sponsoring clinical trial NCT01814072?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.